0 13/11/2023 30/11/2024 2024-11-30 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-11-13 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 15278035 2023-11-13 2024-11-30 15278035 2024-11-30 15278035 2023-11-12 15278035 bus:LeadAgentIfApplicable 2023-11-13 2024-11-30 15278035 bus:Director1 2023-11-13 2024-11-30 15278035 bus:Micro-entities 2023-11-13 2024-11-30 15278035 bus:AuditExemptWithAccountantsReport 2023-11-13 2024-11-30 15278035 bus:SmallCompaniesRegimeForAccounts 2023-11-13 2024-11-30 15278035 bus:PrivateLimitedCompanyLtd 2023-11-13 2024-11-30 15278035 bus:FullAccounts 2023-11-13 2024-11-30
Company registration number: 15278035
NEURONBUILD LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
30 November 2024
NEURONBUILD LIMITED
Contents
Accountant's report
Statement of financial position
NEURONBUILD LIMITED
Report to the board of directors on the preparation of the
unaudited statutory financial statements of Neuronbuild Limited
Period ended 30 November 2024
As described on the statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the period ended 30 November 2024 which comprise the statement of financial position and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions I have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to me.
R M F Pola FCA
Jenemi Associates Limited
2 Low Road
Congham
Kings Lynn
Norfolk
PE32 1AE
31 March 2025
Neuronbuild Limited
Statement of financial position
30 November 2024
30/11/24
£
Fixed assets 100
_______
Net current liabilities -
_______
Total assets less current liabilities 100
_______
Net assets 100
_______
Capital and reserves 100
_______
NEURONBUILD LIMITED
Period ended 30 November 2024
For the period ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 31 March 2025 , and are signed on behalf of the board by:
Mr T C Hill
Director
Company registration number: 15278035
The company is a private company limited by shares, registered in England. The address of the registered office is The Dormers 2 Low Road, Congham, Kings Lynn, Norfolk, PE32 1AE.